Back
Apellis Pharmaceuticals Stock Price Chart
AI Is Changing Marketing Forever-Invest Before the Boom
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
22
APLS
Apellis Pharmaceuticals
Last Price:
$24.66
Seasonality Move:
7.92%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.14 | Sell |
| 20-day SMA: | 26.27 | Sell |
| 50-day SMA: | 28.73 | Sell |
| 200-day SMA: | 33.32 | Sell |
| 8-day EMA: | 25.12 | Sell |
| 20-day EMA: | 26.19 | Sell |
| 50-day EMA: | 28.08 | Sell |
| 200-day EMA: | 34.42 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.2 | Sell |
| Relative Strength Index (14 RSI): | 36.65 | Sell |
| Chaikin Money Flow: | 789697 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.08 - 28.72) | Sell |
| Bollinger Bands (100): | (26.66 - 32.58) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 24.66 while APLS 8-day simple moving average is 25.14, which is a Sell signal.
-
The stock price of APLS is 24.66 while Apellis Pharmaceuticals 20-day SMA is 26.27, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 28.73 while APLS share price is 24.66, making it a Sell technically.
-
APLS stock price is 24.66 and Apellis Pharmaceuticals 200-day simple moving average is 33.32, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
22
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $24.66. The Score for APLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
3.1B
Price in USD:
24.66
Share Volume:
1.4M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
59.91
52-Week Low:
23.77
Sell
22
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 24.66 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 24.66 while APLS 8-day exponential moving average is 25.12, which is a Sell signal.
-
The stock price of APLS is 24.66 while Apellis Pharmaceuticals 20-day EMA is 26.19, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day exponential moving average is 28.08 while APLS share price is 24.66, making it a Sell technically.
-
APLS stock price is 24.66 and Apellis Pharmaceuticals 200-day simple moving average is 34.42, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $1.09 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -1.2, suggesting Apellis Pharmaceuticals is a Sell
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 36.65, which suggest Apellis Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (25.08 - 28.72), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (26.66 - 32.58), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.